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Introduction
Cytomegaloviruses (CMVs) are beta-herpesviruses that establish life-long persistent infection of their hosts. After resolution of acute infection, the virus enters a state of latency during which very few genes are transcribed and no new viral progeny are being generated. Latency is interrupted by occasional reactivations of the virus and expression of genes associated with the lytic virus life-cycle [1] . The success of CMVs as pathogens is a consequence of multiple immunoevasion mechanisms such as downregulation of immunoreceptor ligands or expression of decoy molecules that they employ against every arm of the immune system, including NK cells, which play an important role in the early control of virally infected and malignant cells [2] . Individuals lacking NK cells may suffer from recurrent virus infections, most commonly caused by herpes viruses and papilloma viruses, as well as increased susceptibility to malignant tumors [3] [4] [5] . However, in other cases, there is no obvious clinical immunodeficiency associated with the absence of NK cells, indicating redundancy with other immune compartments for distinct genetic deficiencies [6, 7] . As NK cells also regulate other arms of the immune response, their modulation by CMV can have broader consequences for immunity [8] . For instance, the strength of the primary NK cell response against the virus can have a significant impact on the adaptive immune response, although the underlying mechanisms for this are not yet clear and vary according to host and virus genotypes [9, 10] .
CMV infection is associated with expansion of effector memory CD8 T cell clones that are sustained for the lifetime of the host and can comprise a significant percentage of the total CD8 T cell population in aging individuals [11] . Multiple lines of evidence in experimental animals and in humans which will be discussed in this review, now indicate that CMV infection leaves a similar long-lasting imprint on NK cell phenotype and function, affecting NK cell responses to other pathogens and to vaccination.
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Vaccines facilitate control and eradication of infectious diseases that have plagued humanity for centuries but new infections, including those with pandemic potential continue to emerge.
Understanding the different factors that can influence the response to vaccination is crucial for developing effective vaccines against these new threats. Recent evidence suggests that NK cells can contribute to both the induction and the effector phases of vaccination-induced immunity but that this is dependent upon the CMV-infection status of the vaccinated individual. Here we provide an overview of NK cell biology and development, the manipulation of NK cells by CMVs and the potential impact of CMV evasion strategies on responses to vaccination.
NK cell activity depends on a balance of signals from inhibitory and activating receptors
As first-responders among lymphocytes, NK cells must be able to react quickly to a wide variety of stimuli. They do not possess a single specific antigen receptor but, rather, they express multiple receptors and co-receptors that, synergistically, allow them to recognize potential threats and coordinate responses with other immune cells. Whether an NK cell will attack or tolerate a tumor cell or an infected target cell depends on the net balance of signals transduced by this plethora of receptors. If activating signals prevail, NK cell can kill the offending cell by lysis or induction of apoptosis and/or can secrete cytokines and chemokines to activate other arms of the immune system [12] .
All NK cell receptors are germline-encoded and are often present as co-receptors on other immune cells. Some of these receptors, as well as their ligands, are stochastically expressed which results in heterogeneity in the number and type of receptors expressed by each NK cell within an individual. For example, it has recently been estimated that individual humans may possess between 6,000 and 35,000 phenotypically distinct NK cell subsets [13] . Moreover, in This article is protected by copyright. All rights reserved. some cases both receptors and their ligands are encoded by polygenic loci with a high degree of polymorphism in the population that leads to differences in susceptibility of hosts to infection [14] . Inhibitory NK cell receptors recognize self-molecules that are expressed on healthy cells and as such are responsible for the prevention of autoimmune responses, especially in the context of inflammation. These receptors also play a role in NK cell education and threshold-setting for future activation (reviewed in [15] ). Downregulation of self-molecules can result in absence of inhibitory signals and may lead to "missing-self" recognition [16] . MHC Class I molecules (HLA Class I in humans) are the principal family of self-molecules recognised by inhibitory and activating NK cell receptors [16] [17] [18] .
In humans, there are three different families of NK cell receptors for MHC I: Leukocyte Iglike Receptor (LIR-1), CD94/NKG2 receptors and Killer-cell Immunoglobulin-like Receptors (KIRs). LIR-1 is an inhibitory receptor and recognizes all major groups of MHC Class I, although with varying specificities. CD94/NKG2 receptors can be activating (e.g. CD94/NKG2C) or inhibitory (e.g. NKG2A) but recognize only HLA-E, whereas, activating (short-tailed) and inhibitory (long-tailed) KIRs recognize all classical Class I HLA molecules (A, B and C) but in an allele-specific, and in some cases, peptide-selective manner (reviewed in [19] ). In addition, there are numerous non-MHC Class I ligands for NK cells including the Clr/Ocil ligands that are recognized by inhibitory NKR-PI C-type lectin receptors [20], nectins and nectin-like molecules that are recognized by the activating receptor DNAM-1, inhibitory TIGIT and CD96 that has so far been reported to display both inhibitory (in mouse models) and activating properties [21] [22] [23] [24] . Finally, ligands for activating NK cell receptors can include self and altered-self molecules (including MHC-bound peptides); induced selfligands; foreign, virally encoded molecules; and immune complexes (immunoglobulin Fc binding to CD16) (reviewed in [15, 25] ). Whilst such a wide arsenal of inhibitory and This article is protected by copyright. All rights reserved.
activating NK cell receptors might seem redundant, evolution of diverse receptor-mediated pathways is likely to have been driven by pathogens, including cytomegaloviruses, which have developed mechanisms to interfere with nearly all of these pathways.
Cytomegalovirus-encoded immunoevasins drive host evolution
Cytomegalovirus (CMV) immune evasion strategies target multiple mechanisms in every arm of the immune response, permitting successful dissemination through the population and establishment of life-long, persistent infection. Human cytomegalovirus (HCMV) infects a major portion of the world"s population [26] however due to strict species specificity it cannot be used to infect experimental animals. A number of closely related animal CMVs exist that are used as models; the best established and most widely used is murine CMV (MCMV) [27] due to the availability of numerous mutant mouse and virus strains. Rhesus CMV is highly related to HCMV and shares many gene families, however it is highly prevalent in both wild and captive rhesus monkeys making it difficult and expensive to maintain seronegative animals. Additionally, rhesus monkeys are much more expensive than mice and there are significantly fewer monkey strains available [28] . Finally, CMVs on their own represent excellent model organisms and tools for manipulating the immune system due to the features discussed below.
CMVs modulate NK cell responses by engaging inhibitory and avoiding activating receptors using multiple and often polyfunctional immunoevasins with wide specificities for numerous, often unrelated, targets. Decoy molecules encoded by CMVs preserve cell surface expression of inhibitory ligands whilst engagement of activating receptors is avoided by downregulation of their ligands. Additionally, CMVs encode Fc receptors that interfere with NK-mediated antibody-dependent cell-mediated cytotoxicity(ADCC) and complement attack [29] . The plethora of HCMV and MCMV NK evasins is summarized in Table 1 ; details and This article is protected by copyright. All rights reserved. mechanisms of their action are beyond the scope of this review but can be found elsewhere [9, [29] [30] [31] [32] [33] .
One of the best-described CMV decoy molecules is the MCMV-encoded MHC I-like molecule, m157. Depending on the virus and mouse strain, m157 can engage inhibitory Ly49I and C receptors [34] [35] [36] and the activating Ly49H receptor [37, 38] . It has been proposed that inhibitory Ly49 and KIR receptors predate activating counterparts [39] so it is possible that m157 evolved originally as an inhibitory Ly49 receptor decoy but virusassociated mortality subsequently drove evolution of the activating Ly49H receptor (reviewed in [31] ). However, m157 has only a modest effect on NK cell function in vivo and only in C57BL/6-related mouse strains and it has recently been reported that wild mouse populations lacking Ly49H thrive despite the high prevalence of MCMV infection in the wild [40] . Inhibitory Ly49C is usually engaged in cis interactions with MHC I on NK cells. In cis interactions the receptor is interacting with its ligand present on the same cell and not on the target cell (trans interaction). If a receptor is engaged in cis it is not available for exploitation by m157 expressed in trans. It appears that viral evasion has "selected" inhibitory receptors that can ensure proper NK cell education and functionality in the presence of decoys by engaging in cis [35, 36, 41] (for review on cis and trans interactions of cell surface receptors see [42] ). Similarly, the HCMV-encoded decoy molecule UL18 engages the inhibitory receptor LIR-1 but the availability of LIR-1 is regulated by its cis interactions with HLA molecules [43] . that are better at engaging inhibitory NK cell receptors (HCMV) [32] , or return some MHC I to the cell surface (MCMV) [30] . Moreover, HCMV stabilizes the expression of HLA-E, a ligand for the inhibitory CD94/NKG2A receptor, by providing a mimetic-peptide that overcomes inhibition of peptide loading [32, 44] . However, HLA-E in HCMV infected individuals is also recognized by the activating receptor CD94/NKG2C, although the specificity is much lower and co-engagement of NKG2A and NKG2C still results in inhibition of NK cell [45] . Nevertheless, the evolutionary pressure exerted by this recognition is sufficient to select for HCMV strains with polymorphisms that abrogate recognition by NKG2C but not NKG2A [46] , at least in transplant patients. The impact of these polymorphisms on the expansion of CD94/NKG2C + NK cells during HCMV infection is not yet known.
Missing self-recognition can also be mediated by non-MHC I molecules; one such example is the MCMV-encoded decoy m12 that targets the inhibitory NKR-P1B receptor [47] [48] [49] , and is assumed to have driven the evolution of the related activating receptor, NKR-P1C (NK1.1), that also recognizes m12 in a mouse-and virus strain-dependent manner [50] . The SLAM family of receptors (SFR) have also been shown to aid in MHC-I-dependent missing-self recognition [51] . The ongoing evolutionary arms race between viral immunoevasins and host defenses is also evident in the evasion of activating receptor NKG2D, with CMVs encoding multiple strategies to prevent surface expression of NKG2D ligands (Table 1) . Finally, in silico models show that CMV-like viruses that modulate NK cell ligands and downregulate MHC I, can select for genetically diverse and highly allele-specific receptor families with activating and inhibitory members, such as KIR and Ly49 [52] [53] [54] [55] .
Influence of CMV on NK cell education
Binding of self-molecules via inhibitory receptors is also required for NK cell education and modulation of effector function. Since NK cell inhibitory receptors and their ligands are encoded by distinct loci located on different chromosomes, it is possible for some NK cells to express inhibitory NK cell receptors for which there is no self-ligand. Potential autoreactivity of such cells is prevented by a mechanism termed "licensing" or "disarming": if an NK cell does not encounter a ligand for at least one inhibitory receptor during its maturation it becomes hyporesponsive towards targets with low or no MHC I (reviewed in [56] ). In mouse models, NK cell responsiveness increases with each inhibitory receptor that can find its ligand during maturation [12, 57] . The tuning of NK cell responsiveness is not restricted only to the maturation stages, rather it"s a continuous process depending on the availability of receptor ligands. Unlicensed cells are not redundant; the inflammatory environment can ameliorate their anergy and they can be effective against targets that express self-MHC I that would inhibit licensed cells, such as MHC I-expressing tumors or viruses such as CMV that encode NK cell inhibitory receptor decoys (reviewed in [12, 57] ). Conversely, NK cells in mice that overexpress or constitutively express ligands for NKG2D or Ly49H receptor displayed tolerance against targets expressing these ligands (reviewed in [12, 58] ).
NK cell education can also be mediated by non-MHC I self-molecules [59] . For example, the SFR that have been shown to act as both inhibitory and activating receptors depending on adaptor molecules [60] , can play a significant role in tuning of NK cell responsiveness although it is not yet clear whether this tuning is a consequence of their activating or inhibitory role [61, 62] . MCMV and HCMV regulate the expression of one SFR, 2B4 (Table   1 ) [63, 64] . It is not known whether other SFRs are targeted by CMVs however, a recent
work demonstrated in mice that SFRs and their adaptor molecules are promising modulators that can enhance immune responses to vaccines [65] .
Although expression of NK cell receptors is often described as stochastic, a growing body of research reveals the impact of inhibitory receptor signaling during NK cell maturation on the expression of other NK cell receptors (reviewed in [12] ). For example, signaling from activating NK cell receptors via SLP-76 changes the expression of inhibitory Ly49A, Ly49G2 and Ly49I receptors in mice and completely abolishes acquisition of KIR2DL1, KIR2DL2/DL3, and KIR3DL1 in human NK cells and it has been proposed that this is driven by the expression of activating ligands on bone marrow stromal cells [66] . Interestingly, cytomegaloviruses have a wide cell and tissue tropism including bone marrow stromal cells, a tissue that is important for generation and maintenance of NK cells, and, in an influenza model, the bone marrow was found to be an important site of proliferation of long-lived memory-like NK cells [67] . It will be interesting to see whether bone marrow stroma influences the generation of CMV-induced memory-like NK cells and whether latent CMV in the bone marrow modulates NK cell maturation and education.
Long-term impact of MCMV on NK cell phenotype, behavior and responses to other pathogens
Following infection or vaccination, pathogen-specific cells of the adaptive immune response undergo clonal expansion (proliferation) and differentiation followed by contraction of the effector cell pool and formation of long-lived, highly antigen-specific memory cells with the ability to mount fast and efficient recall responses. While most NK cell receptors are not antigen specific, in certain mouse strains the activating Ly49H receptor specifically recognizes MCMV m157, as described above ( [37, 38] and reviewed in [68] ). However, this pathogen-specific recognition is restricted only to C57BL/6 and related mice and a few
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HCMV infection leads to accumulation of terminally differentiated NK cells with potential long-term consequences
Human CMV infection is characterized by accumulation of highly differentiated subsets of [76] . This observation has now been corroborated in HCMV-infected children [77] , in adults undergoing acute HCMV infection [78] and in hematopoietic stem cell were poorly responsive to IL12/IL18 and expressed lower levels of NKp46 [88] .
Cytokine-induced memory-like NK cells in CMV infection and vaccination
This article is protected by copyright. All rights reserved. [119, 122, 124] but also induce CIMLs [97, 119, 124, 127] . In sharp contrast to CMV infection, however, vaccination and cytokinemediated pre-activation lead to a temporary expansion (or redistribution) of less differentiated CD56 bright and CD57-CD56 dim NK cell subsets [97, 119, 124, 125, 127] but these eventually revert to pre-vaccination levels. For example, the elevated cytokine driven response observed after influenza or yellow fever 17D vaccination of Europeans persisted for up 3 months [104, 127] , the response to influenza or DTPiP vaccination of Gambians lasted for up to 6 months and the response to BCG vaccination in South Africans lasted for up to 1 year [97, 124] .
Broader effects of HCMV exposure on vaccination outcomes
A broader influence of HCMV infection on vaccine induced immunity has been inferred from several studies comparing naturally occurring or vaccine-induced antibody levels or T cell responses against distinct pathogens in HCMV + to HCMV-individuals. For anti-influenza responses, the impact of HCMV infection can be positive or negative depending on age and the immune readout. Poor overall health indicators have been associated with higher HCMV antibody titres, higher NK cell frequencies and lower B cell frequencies in the elderly [128] and inverse correlations have been reported between anti-HCMV IgG titres and vaccinationinduced antibodies to influenza in the elderly [128] and in healthy young adults [129, 130] .
Other studies have demonstrated either higher [131] or lower [132] antibody responses to influenza vaccination in HCMV-compared to HCMV + young adults, suggesting that the 
The impact of HCMV infection on NK cell responses to vaccine antigens
The impact of HCMV infection on vaccine antigen or cytokine-driven response pathways can be profound.
In vitro NK cell IFN- responses to several previously encountered vaccine
antigens, including Influenza, whole cell pertussis and DTPiP (alone or co-stimulated with low concentrations of IL-12 and IL-18) are impaired in HCMV + individuals [95, 97, 119] .
This effect is consistent with the well-documented impairment of NK cell IFN- and CD25
responses to exogenous cytokines among HCMV + individuals [95, 118, 119, 136, 137] , and suggests that HCMV infection impairs the NK cell response to vaccine antigen-induced IL-2 [95, 119] . As demonstrated for CIML, post-vaccination, NK cells appear to be reliant on cytokine-driven induction of CD25 for their maintenance and function, raising the possibility that production of, or responses to, the costimulatory cytokines (type I IFNs, IL-12 or IL-18) that are required for CD25 induction may be reduced in HCMV + individuals [113, 119] . This subjects [124] . The boosting of cytokine-driven responses in all of these studies preferentially expands or activates less differentiated subpopulations of NK cells.
Receptor-mediated activation and ADCC in the context of CMV infection and vaccination
Whilst CMV infection negatively influences vaccine-driven responses that are reliant on accessory cytokines, NK cell activation via other pathways can also be adversely affected by CMV infection. For example, murine Ly49H + "memory-like" NK cells rely on co-stimulation via DNAM-1 and its induced ligands on macrophages and dendritic cells [138] ; CMVmediated down regulation of these ligands may have consequences for responses to infection or vaccination. Similarly, in humans, reduced expression of NKp46, and reduced NKp46 signalling capacity in adaptively expanded NK cells in HCMV+ individuals [92, 136, 137] , could compromise responses to influenza virus by inhibiting the costimulatory interaction between NKp46 and viral haemaglutinin [139] . Moreover, US12-mediated down regulation of B7-H6 (a key ligand for NKp30) on HCMV-infected fibroblasts can lead to reduced NK cell degranulation [140] . However, CD94/NKG2C + NK cells show enhanced cytotoxic activity against a range of tumour cell lines which vary greatly in their expression of HLA-E, indicating that there may be conserved expression of receptors for other activating ligands [141] . Indeed, HCMV-expanded NK cells rely on signalling via accessory receptors including CD2 and its ligand, CD58, on accessory cells [88, 89] . On the other hand, HCMVexpanded, "adaptive", CD94/NKG2C + CD57 + NK cells express high levels of CD16, signal very effectively via CD3ζ and possess epigenetic modifications leading to enhanced receptormediated cytotoxicity and IFN- production [92, 93] . Together these modifications lead to greatly enhanced capacity for CD16-mediated ADCC, which may compensate for their loss of cytokine responsiveness [83, 86, 87, 92] . Interestingly, HCMV-expanded memory-like NK This article is protected by copyright. All rights reserved.
cells do not appear to target autologous CD4+ T cells [96] , a regulatory feature of NK cells described in murine models of virus-induced immune responses [142] . Such preservation of pathogen or vaccine-specific CD4+ T cells is likely to be important for the maintenance of both vaccine induced CIML and HCMV-associated, adaptive NK cell expansions.
Concluding remarks:
Although it is clear that cytomegaloviruses are major drivers of cellular immune [140, [161] [162] [163] US18, US20* lysosomal degradation of full length MICA [164] US12, US13 proteasomal degradation of ULBP-2, [140] This article is protected by copyright. All rights reserved.
* US2 and US12 family members have been shown to target multiple membrane proteins [140, 175] whose relevance to NK cell immune evasion is not yet clear. In addition, deletion of individual US12 family members resulted in changes in NK cell reactivity towards infected cells [175] however the receptors mediating this recognition not yet known.
and US20 MICB and UL16 miR-UL112 inhibition of MICB mRNA translation [165] UL142 downregulation of full-length MICA and ULBP3 from the cell surface [166, 167] 
